Search results for "Tracte gastrointestinal Malalties"
showing 3 items of 3 documents
BD MAX Enteric Bacterial, Bacterial Plus, and Virus Panels for Diagnosis of Acute Infectious Gastroenteritis: a Cost-Benefit Analysis
2022
Economic assessment is required to gauge the value of implementing PCR syndromic platforms in the microbiology laboratory for the diagnosis of community-acquired acute gastroenteritis (AGE) in pediatric and adult in- and outpatients. A cost-benefit analysis was conducted from a health care system perspective using BD MAX Enteric Bacterial, Bacterial Plus, and Virus panels. Two 6-month periods were selected, in which either conventional procedures (in 2017) or BD MAX PCR multiplex panels (in 2018) were used. We retrospectively reviewed medical records of all patients with positive results and a representative sample of negative ones. A Markov model was used to represent transition probabilit…
Suplementos probióticos en enfermedades del entorno gastrointestinal por alteración de la microbiota tras la antibioterapia
2022
Introducción: La microbiota puede verse alterada debido al uso de antibióticos para el tratamiento de enfermedades del entorno gastrointestinal. La suplementación con probióticos podría emplearse terapéuticamente para regular o evitar esta disbiosis. Objetivo: Analizar la información relevante sobre el uso de probióticos como coadyuvante en el tratamiento con antibióticos en enfermedades del entorno gastrointestinal que pueden alterar su microbiota. Métodos: Revisión bibliográfica en bases de datos científicas de artículos relacionados con el tema y publicados entre enero de 2010 a junio de 2020. Se encontraron 132 artículos, 43 se incluyeron tras cumplir los criterios de selección, relevan…
Effect of milk based fruit beverage enriched with plant sterols and/or galactooligosaccharides in a murine chronic colitis model
2019
The potential anti-inflammatory effect of plant sterols (PS) enriched milk-based fruit beverages (PS, 1 g/100 mL) (MfB) with/without galactooligosaccharides (GOS, 2 g/100 mL) (MfB-G) in an experimental mice model of chronic ulcerative colitis was evaluated. Beverages were orally administered to mice every day by gavage to achieve PS and GOS doses of 35 and 90 mg/kg, respectively, and experimental colitis was induced by giving mice drinking water ad libitum containing 2% (w/v) dextran sulphate sodium (DSS) for 7 days, alternating with periods without DSS up to the end of the study (56 days). MfB beverage showed significant reduction of symptoms associated to ulcerative colitis and improved t…